←
Chad Newton28 posts
Chad Newton avatar

Chad Newton

@cnewto

pulmonologist/researcher @UTSW supporting patients with pulmonary fibrosis.

◷ Joined October 2011
Liz Hankollari avatar
⟳ Chad Newton retweeted
Liz Hankollari@LizHankollariMD·7 Feb 2020

ICYMI: TLC (Tom/Li/Chad) and ELC with DHJ. @dhjutsw1 thanks for everything. Keep us posted on your next adventures! @DinoKazi

Post attachment
Naftali Kaminski avatar
⟳ Chad Newton retweeted
Naftali Kaminski@KaminskiMed·8 Nov 2019

Dr. Imre Noth retracing the history of genetics & pharmacogenomics In Pulmonary Fibrosis: “The greatest thing we did for the field is stopping treating patients with Prednisone & Azathioprine”. Me: Amen! #PFFSummit #CurePF #FightPF

Post attachment
Naftali Kaminski avatar
⟳ Chad Newton retweeted
Naftali Kaminski@KaminskiMed·8 Nov 2019

Dr. Christine García: Congratulations to the Pulmonary Fibrosis Foundation & all other advocacy groups for their success in increasing awareness - this conference is an amazing testimony of this success & an a predictor of future success! #PFFSummit2019 #FightPF #CurePF

Post attachment
ERS publications avatar
⟳ Chad Newton retweeted
ERS publications@ERSpublications·12 Apr 2019

Leukocyte telomere length and MUC5B minor allele frequency are similar for IPAF and the combined CTD-ILD group; however, the associations between these genomic markers and clinical outcomes are different for these two types of ILD ow.ly/wXem30njRkg

Post attachment
John Kim avatar
⟳ Chad Newton retweeted
John Kim@jskim8223·15 Jan 2019

Great work by @cnewto @drdayjee,etc. Shorter telom length and Muc5B SNP assoc w/ worse outcomes and survival in IPAF (diff from IPF w/Muc5B and survival). IPF with shorter telo did worse with immunosupp @UTSWIMchief @UTSWIMJW ncbi.nlm.nih.gov/pubmed/3056… ncbi.nlm.nih.gov/pubmed/3056…